Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
about
Ability of HIV-1 Nef to downregulate CD4 and HLA class I differs among viral subtypesMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allImpacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivoRev-RRE Functional Activity Differs Substantially Among Primary HIV-1 Isolates.Retroviral vectors for analysis of viral mutagenesis and recombination.Lower HIV provirus levels are associated with more APOBEC3G protein in blood resting memory CD4+ T lymphocytes of controllers in vivo.Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllersThe activity spectrum of Vif from multiple HIV-1 subtypes against APOBEC3G, APOBEC3F, and APOBEC3HHIV-1 and HIV-2 exhibit similar mutation frequencies and spectra in the absence of G-to-A hypermutation.APOBEC3G Variants and Protection against HIV-1 Infection in Burkina Faso.APOBEC3G expression and hypermutation are inversely associated with human immunodeficiency virus type 1 (HIV-1) burden in vivo.Retroelements versus APOBEC3 family members: No great escape from the magnificent sevenSingle-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra.Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its Vif proteinHost restriction factors in retroviral infection: promises in virus-host interaction.DNA damage enhances integration of HIV-1 into macrophages by overcoming integrase inhibition.Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression LevelsAccessory genes confer a high replication rate to virulent feline immunodeficiency virus.Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypesA comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress.APOBEC3G oligomerization is associated with the inhibition of both Alu and LINE-1 retrotranspositionSubtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.In vitro functional assessment of natural HIV-1 group M Vpu sequences using a universal priming approach.Determinants of efficient degradation of APOBEC3 restriction factors by HIV-1 Vif.Association of single nucleotide polymorphisms of APOBEC3G with susceptibility to HIV-1 infection and disease progression among men engaging in homosexual activity in northern China.MARCH8 inhibits HIV-1 infection by reducing virion incorporation of envelope glycoproteins.Patterns of genomic site inheritance in HIV-1M inter-subtype recombinants delineate the most likely genomic sites of subtype-specific adaptation.
P2860
Q21245213-E6012457-5827-4F2D-A33D-87B57DFD4F1AQ26823568-B0E10A0C-BA17-4E3E-AA3B-AF7A58911C75Q26851152-F124A8D8-A2F6-4D87-8E76-325B86801DBAQ30276860-55B0CCA5-6E94-4DFA-8701-79431E0271B1Q34303615-84E95741-583D-4AF5-A4DC-EA6006DC9551Q35022585-E08183F5-3D9D-404E-94CE-FC8C09B7A476Q35489088-ABE9B03B-052D-4BC9-A540-AA4D10D47E47Q35666084-1A3A704D-BCCD-46C9-B302-22DA3AFC99DBQ35834559-F4B893AA-2C71-4672-8F5E-7DFBDBE1A24FQ35888106-BB11555B-60A9-4C4F-AF8A-D76B7B4F978FQ36019696-A75BDEA4-8D0A-48E4-9552-D48A09A88534Q36162443-F3DB814C-C035-4FE2-B8D2-2EE248F5513CQ36371387-A976E5ED-F25C-47B3-A457-DE5E213F8755Q36432758-10621692-26B8-4930-851A-840A5E83A301Q36548179-273047D2-24B1-435F-B473-1EE590A09ECBQ36707275-B5224FC1-C92F-4AC7-91AF-709E1754B9F2Q36811895-32F4D755-81B1-4D64-9CE5-DA9434604D5EQ36978615-807894D8-B9CC-4A12-8225-3F05359D5658Q37047737-57E70F1F-70E3-438A-8C85-D008BD5EC12FQ37141248-A706C88A-0002-47D8-BACD-18F61BE8B4DBQ37404667-5F6BA294-6EA8-4F10-B698-12C068CABECBQ38706845-575077E5-AFDB-463C-8963-3C7D0AA65242Q38730130-C1111C63-6567-4FE8-9BFB-EDF383B9B17EQ38951329-5A85993A-FBF3-4769-96A0-959975E94A1BQ40509727-9755D2DA-72C5-4141-A38C-02B7CD9C7FA5Q40927400-46BA885D-973F-4160-A999-EB0B494C7C84Q55363352-4308C78D-7A7F-47F9-8DDD-B94817E35734
P2860
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@ast
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@en
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@nl
type
label
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@ast
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@en
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@nl
prefLabel
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@ast
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@en
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@nl
P2093
P2860
P356
P1476
Differential anti-APOBEC3G activity of HIV-1 Vif proteins derived from different subtypes
@en
P2093
David Nolan
Hideaki Fujita
Mari Shimura
Masanobu Kinomoto
Masashi Tatsumi
Simon Mallal
Yoshitaka Tanaka
Yukie Iwabu
Yukihito Ishizaka
P2860
P304
35350-35358
P356
10.1074/JBC.M110.173286
P407
P577
2010-09-10T00:00:00Z